S
Soley Therapeutics
Biotech & Life Sciences · Brentwood, United States · Founded 2020
Drug discovery and development company using cellular responses and AI to identify novel therapies for complex diseases MoreLess
Soley Therapeutics operates in the life sciences sector, focusing on the discovery and development of new drugs. The company utilizes a groundbreaking high throughput platform technology that uses cells as natural sensors to interpret nuanced cellular responses. This technology, combined with the power of artificial intelligence (AI) and machine learning (ML), allows Soley Therapeutics to efficiently and effectively identify potential drug candidates. The company serves pharmaceutical and biotechnology firms, aiming to meet the unmet needs of patients by revolutionizing drug discovery and development. Soley Therapeutics generates revenue through partnerships, licensing agreements, and the sale of developed drugs. The company is committed to scientific rigor, continuous innovation, and creating benefits for patients in need. It also prioritizes an attractive work environment that stimulates and rewards collegiality, creativity, and disciplined productivity. Soley Therapeutics is based in San Francisco and is actively expanding its team of scientists, high throughput screening automation experts, security and IT specialists, and AI/ML engineers.
Keywords: drug discovery, AI, ML, high throughput, biotechnology, pharmaceutical, cellular response, innovation, San Francisco, unmet needs.
Company overview
Soley Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Brentwood, United States
- Employees
- 37
- Open positions
- 2
- Dealroom signal
- 81.2
Valuation & funding
Soley Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jan 2026 | $200M | $800M | Breyer Capital · HRTG Partners · RWN Management · GordonMD Global Investment | ↗ |
| SERIES BOther financing | Jan 2022 | $70M | $280M | Undisclosed | ↗ |
| SERIES AOther financing | Dec 2020 | $20M | $80M | Undisclosed | ↗ |
| SPINOUTOther financing | Jan 2020 | $0 | — | University of California, San Francisco | — |
Growth signals
Soley Therapeutics website traffic
Latest recorded traffic for Soley Therapeutics is 2.5K monthly website visits, down 16.7% over the last three months. Soley Therapeutics's team grew 2.8% over the past year.
Hiring
Open positions at Soley Therapeutics
Current openings linked to this company in Dealroom.
Comparisons
Soley Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Soley Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Soley Therapeutics has talent and traffic
team presence
In the news
Latest news about Soley Therapeutics
Recent press, funding announcements, and product moves mentioning Soley Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Soley Therapeutics
An AI-synthesized read of the highest-engagement posts about Soley Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Soley Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.